European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

AURIMOD GmbH, Vienna, Austria

Watch
AURIMOD GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

AURIMOD GmbH
SzeleSTIM GmbH

Identification

Fb
Firmenbuch 442018b
Lei
529900979YPDTUUU5I94
EUID
ATBRA.442018-000

Address

Modecenterstraße 22/Top Nr D29, 1030 Wien, Austria

Corporate purpose

Medical device development, manufacturing and distribution

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
2Managing Director
1Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
13 known active shareholders
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Employee number
Revenue per employee
Cash on hand
Receivables
Liabilities
Real estate
Patents
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2016 to 2025
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

10 Jul 2026
Annual report for the year ending 31/12/2025 · Balance sheet for 31/12/2025
13 May 2026
Patent: Device for Auricular Nerve Stimulation
3 Apr 2026
Shareholder (1) · No longer Shareholder (1) · Capital: €2,280,000
6 Mar 2026
Managing Director: Manuel Leal Garcia · Name: AURIMOD GmbH
9 Oct 2025
Shareholder (3) · Shareholder (4 companies) · Capital: €2,280,000
22 Aug 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024
8 Jul 2025
Managing Director: Manuel Leal Garcia
2 Jul 2025
Patent: Electrode array and electrode for peripheral nerve stimulation
18 Jun 2025
Patent: Device for auricular punctual stimulation
14 May 2025
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
13 May 2025
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
8 May 2025
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
8 May 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023
28 Apr 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023
1 Oct 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023
1 Jul 2024
Patent: Device for Transcutaneous Auricular Nerve Stimulation
3 May 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
3 Apr 2024
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
20 Mar 2024
Shareholder: ILUM Tec GmbH · Capital: €1,850,000
8 Mar 2024
Authorized signatory (ppa): Bernhard Fabian
17 Nov 2023 in Sat
State Aid (€198,148): Extension of the Research Directive/18 - 21 extended until 31.12.2023 (Vienna)
18 Jul 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
23 Aug 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
22 Jul 2022
No longer Shareholder (1) · Shareholder: ILUM Tec GmbH · Capital: €1,500,000
15 Jul 2022
Shareholder (2) · Shareholder: AVADOS GmbH, ILUM Tec GmbH · Capital: €1,500,000
23 Jun 2022
No longer Shareholder (3) · Shareholder: ILUM Tec GmbH · Capital: €1,115,000
19 May 2022
Managing Director: Stefan Kampusch · No longer Managing Director: Michael Hammerschmid · No longer Authorized signatory (ppa): Stefan Kampusch
4 Apr 2022
Patent: Electrode Array and Electrode for Peripheral Nerve Stimulation
29 Mar 2022
Patent: Device for auricular punctual stimulation
18 Mar 2022
Shareholder: ILUM Tec GmbH · Capital: €1,115,000
18 Jan 2022
Address
31 Dec 2021
Annual report according to KAGB, VermAnIG for the financial year from 01.01.2021 to 31.12.2021
17 Dec 2021
Word figurative mark: “VIVO“
3 Dec 2021
Name: Aurimod GmbH
30 Sept 2021 as SzeleSTIM GmbH
Shareholder (3) · Shareholder: AVADOS GmbH · Capital: €465,000
6 Aug 2021 as SzeleSTIM GmbH
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
3 Aug 2021 as SzeleSTIM GmbH
Shareholder (2) · No longer Shareholder (1) · Capital: €465,000
30 Jul 2021 as SzeleSTIM GmbH
Managing Director: Michael Hammerschmid · Authorized signatory (ppa): Stefan Kampusch · No longer Managing Director: Stefan Kampusch · No longer Shareholder (1) · SH: ILUM Tec GmbH · Capital: €465,000
15 Jun 2021 as SzeleSTIM GmbH
State Aid (€400,000): COVID-19: Third amendment of SA.56981 (2020/N): Austrian guarantee scheme on bridge loans under the Temporary Framework for State aid measures to support the economy in the …
24 May 2021
Wordmark: “AURIMOD“
3 Feb 2021 as SzeleSTIM GmbH
Shareholder (3) · Shareholder: ILUM Tec GmbH · Capital: €465,000
30 Jan 2021 as SzeleSTIM GmbH
Shareholder (11) · Shareholder: AVADOS GmbH, ILUM Tec GmbH · Capital: €465,000
29 Jan 2021 as SzeleSTIM GmbH
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
12 Jan 2021 as SzeleSTIM GmbH
Shareholder (5) · Shareholder: ILUM Tec GmbH · Capital: €465,000
1 Dec 2020 as SzeleSTIM GmbH
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
13 Oct 2020 as SzeleSTIM GmbH
Capital: €35,000
11 Sept 2020 as SzeleSTIM GmbH
Shareholder (1) · No longer Shareholder (1) · Capital: €35,000
14 Jan 2020 as SzeleSTIM GmbH
Address
3 Oct 2019 as SzeleSTIM GmbH
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
1 Oct 2019 in Hor
EU funding (€2,196,747): From pills to bio-electronics: a wearable neurostimulator for the personalised treatment of chronic pain
29 Jun 2019 as SzeleSTIM GmbH
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
24 Apr 2019 as SzeleSTIM GmbH
Managing Director: Stefan Kampusch · No longer Managing Director: Jozsef C. Széles · No longer Authorized signatory (ppa) (1)
4 Apr 2019 as SzeleSTIM GmbH
Shareholder (8) · Shareholder: AVADOS GmbH · Capital: €35,000
13 Oct 2018 as SzeleSTIM GmbH
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
1 Jan 2018 in Hor
EU funding (€50,000): From pills to bio-electronics: a wearable anti-inflammatory treatment for prevention of Peripheral Arterial Disease.
21 Oct 2017 as SzeleSTIM GmbH
Annual report for the year ending 31/12/2016 (only announcement)
21 Feb 2017 as SzeleSTIM GmbH
Shareholder (1) · Shareholder: AVADOS GmbH · Capital: €35,000
16 Nov 2016 as SzeleSTIM GmbH
Annual report for the year ending 31/12/2015 (only announcement)
5 Nov 2015 as SzeleSTIM GmbH
Reg­is­tra­tion: 05/11/2015 · MD: J. S. · SH (4) · ppa (1) · SH: AVADOS GmbH · Address · Deadline for annual balance: 31.12. · Capital: €35,000 · Seat: Vienna, Austria …
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.